Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Sulforaphane from Broccoli Reduces Symptoms of Autism: A Follow-up Case Series from a Randomized Double-blind Study.

Lynch R, Diggins EL, Connors SL, Zimmerman AW, Singh K, Liu H, Talalay P, Fahey JW.

Glob Adv Health Med. 2017 Oct 26;6:2164957X17735826. doi: 10.1177/2164957X17735826. eCollection 2017.

2.

New Assessments and Treatments in ASD.

Choueiri RN, Zimmerman AW.

Curr Treat Options Neurol. 2017 Feb;19(2):6. doi: 10.1007/s11940-017-0443-8. Review.

PMID:
28251588
3.

Sulforaphane Treatment of Young Men with Autism Spectrum Disorder.

Singh K, Zimmerman AW.

CNS Neurol Disord Drug Targets. 2016;15(5):597-601.

PMID:
27071786
4.

Sleep in Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder.

Singh K, Zimmerman AW.

Semin Pediatr Neurol. 2015 Jun;22(2):113-25. doi: 10.1016/j.spen.2015.03.006. Epub 2015 Mar 26. Review.

PMID:
26072341
5.

Reply to Scahill: Behavioral outcome measures in autism.

Talalay P, Zimmerman AW.

Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):E350. doi: 10.1073/pnas.1422473112. Epub 2015 Jan 13. No abstract available.

6.

Sulforaphane treatment of autism spectrum disorder (ASD).

Singh K, Connors SL, Macklin EA, Smith KD, Fahey JW, Talalay P, Zimmerman AW.

Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15550-5. doi: 10.1073/pnas.1416940111. Epub 2014 Oct 13.

7.

Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay.

Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I.

Pediatrics. 2014 May;133(5):e1241-8. doi: 10.1542/peds.2013-3406. Epub 2014 Apr 14.

8.

Neuroscience. Could autism be treated prenatally?

Zimmerman AW, Connors SL.

Science. 2014 Feb 7;343(6171):620-1. doi: 10.1126/science.1250214. No abstract available.

PMID:
24503843
9.

Association between regression and self injury among children with autism.

Lance EI, York JM, Lee LC, Zimmerman AW.

Res Dev Disabil. 2014 Feb;35(2):408-13. doi: 10.1016/j.ridd.2013.11.014. Epub 2013 Dec 14.

PMID:
24342713
10.

Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.

Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I.

Autism Res. 2013 Jun;6(3):149-68. doi: 10.1002/aur.1288. Epub 2013 Mar 14. Review.

PMID:
23495208
11.

Altered postnatal cell proliferation in brains of mouse pups prenatally exposed to IgG from mothers of children with autistic disorder.

Kadam SD, French BM, Kim ST, Morris-Berry CM, Zimmerman AW, Blue ME, Singer HS.

J Exp Neurosci. 2013 Nov 13;7:93-9. doi: 10.4137/JEN.S12979. eCollection 2013.

12.

Maternal antibody reactivity to lymphocytes of offspring with autism.

Bressler JP, Gillin PK, O'Driscoll C, Kiihl S, Solomon M, Zimmerman AW.

Pediatr Neurol. 2012 Nov;47(5):337-40. doi: 10.1016/j.pediatrneurol.2012.06.017.

PMID:
23044014
13.

Co-occurring conditions and change in diagnosis in autism spectrum disorders.

Close HA, Lee LC, Kaufmann CN, Zimmerman AW.

Pediatrics. 2012 Feb;129(2):e305-16. doi: 10.1542/peds.2011-1717. Epub 2012 Jan 23.

PMID:
22271695
14.

Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders.

Croen LA, Connors SL, Matevia M, Qian Y, Newschaffer C, Zimmerman AW.

J Neurodev Disord. 2011 Dec;3(4):307-15. doi: 10.1007/s11689-011-9093-4. Epub 2011 Aug 27.

15.

In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.

Witter FR, Zimmerman AW, Reichmann JP, Connors SL.

Am J Obstet Gynecol. 2009 Dec;201(6):553-9. doi: 10.1016/j.ajog.2009.07.010. Review.

PMID:
19961985
16.

Childhood serum anti-fetal brain antibodies do not predict autism.

Morris CM, Zimmerman AW, Singer HS.

Pediatr Neurol. 2009 Oct;41(4):288-90. doi: 10.1016/j.pediatrneurol.2009.04.014.

PMID:
19748049
17.

Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model.

Singer HS, Morris C, Gause C, Pollard M, Zimmerman AW, Pletnikov M.

J Neuroimmunol. 2009 Jun 25;211(1-2):39-48. doi: 10.1016/j.jneuroim.2009.03.011. Epub 2009 Apr 10.

PMID:
19362378
18.

Variation in season of birth in singleton and multiple births concordant for autism spectrum disorders.

Lee LC, Newschaffer CJ, Lessler JT, Lee BK, Shah R, Zimmerman AW.

Paediatr Perinat Epidemiol. 2008 Mar;22(2):172-9. doi: 10.1111/j.1365-3016.2007.00919.x.

PMID:
18298692
19.

Fetal mechanisms in neurodevelopmental disorders.

Connors SL, Levitt P, Matthews SG, Slotkin TA, Johnston MV, Kinney HC, Johnson WG, Dailey RM, Zimmerman AW.

Pediatr Neurol. 2008 Mar;38(3):163-76. doi: 10.1016/j.pediatrneurol.2007.10.009. Review.

PMID:
18279750
20.

A hot spot of genetic instability in autism.

Eichler EE, Zimmerman AW.

N Engl J Med. 2008 Feb 14;358(7):737-9. doi: 10.1056/NEJMe0708756. Epub 2008 Jan 9. No abstract available.

PMID:
18184953
21.

Antibodies against fetal brain in sera of mothers with autistic children.

Singer HS, Morris CM, Gause CD, Gillin PK, Crawford S, Zimmerman AW.

J Neuroimmunol. 2008 Feb;194(1-2):165-72. Epub 2008 Feb 21.

PMID:
18093664
22.

Behaviors associated with fever in children with autism spectrum disorders.

Curran LK, Newschaffer CJ, Lee LC, Crawford SO, Johnston MV, Zimmerman AW.

Pediatrics. 2007 Dec;120(6):e1386-92.

PMID:
18055656
23.

Smith-Lemli-Opitz syndrome and autism spectrum disorder.

Bukelis I, Porter FD, Zimmerman AW, Tierney E.

Am J Psychiatry. 2007 Nov;164(11):1655-61. No abstract available.

PMID:
17974928
24.

Distinct kinetic and mechanical properties govern ALCAM-mediated interactions as shown by single-molecule force spectroscopy.

Te Riet J, Zimmerman AW, Cambi A, Joosten B, Speller S, Torensma R, van Leeuwen FN, Figdor CG, de Lange F.

J Cell Sci. 2007 Nov 15;120(Pt 22):3965-76. Epub 2007 Oct 30.

25.

Developmental regression and autism reported to the Vaccine Adverse Event Reporting System.

Woo EJ, Ball R, Landa R, Zimmerman AW, Braun MM; VAERS Working Group.

Autism. 2007 Jul;11(4):301-10.

PMID:
17656395
26.

Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism.

Zerrate MC, Pletnikov M, Connors SL, Vargas DL, Seidler FJ, Zimmerman AW, Slotkin TA, Pardo CA.

J Pharmacol Exp Ther. 2007 Jul;322(1):16-22. Epub 2007 Mar 30.

PMID:
17400887
27.

Autism.

Tesini D, Friedman C, Connors SL, Zimmerman AW.

J Am Dent Assoc. 2007 Mar;138(3):286-8; author reply 288, 290, 292. No abstract available.

PMID:
17332028
28.

beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort.

Cheslack-Postava K, Fallin MD, Avramopoulos D, Connors SL, Zimmerman AW, Eberhart CG, Newschaffer CJ.

Mol Psychiatry. 2007 Mar;12(3):283-91. Epub 2007 Jan 2.

PMID:
17199132
29.

HLA-DR4 in families with autism.

Lee LC, Zachary AA, Leffell MS, Newschaffer CJ, Matteson KJ, Tyler JD, Zimmerman AW.

Pediatr Neurol. 2006 Nov;35(5):303-7.

PMID:
17074598
30.

Maternal antibrain antibodies in autism.

Zimmerman AW, Connors SL, Matteson KJ, Lee LC, Singer HS, Castaneda JA, Pearce DA.

Brain Behav Immun. 2007 Mar;21(3):351-7. Epub 2006 Oct 6.

PMID:
17029701
31.

Plasma serotonin in autism.

Connors SL, Matteson KJ, Sega GA, Lozzio CB, Carroll RC, Zimmerman AW.

Pediatr Neurol. 2006 Sep;35(3):182-6.

PMID:
16939857
32.

Antibrain antibodies in children with autism and their unaffected siblings.

Singer HS, Morris CM, Williams PN, Yoon DY, Hong JJ, Zimmerman AW.

J Neuroimmunol. 2006 Sep;178(1-2):149-55. Epub 2006 Jul 13.

PMID:
16842863
33.

Developmental regression and mitochondrial dysfunction in a child with autism.

Poling JS, Frye RE, Shoffner J, Zimmerman AW.

J Child Neurol. 2006 Feb;21(2):170-2.

34.

beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins.

Connors SL, Crowell DE, Eberhart CG, Copeland J, Newschaffer CJ, Spence SJ, Zimmerman AW.

J Child Neurol. 2005 Nov;20(11):876-84.

PMID:
16417856
35.

Immunity, neuroglia and neuroinflammation in autism.

Pardo CA, Vargas DL, Zimmerman AW.

Int Rev Psychiatry. 2005 Dec;17(6):485-95. Review.

PMID:
16401547
36.

Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.

Zimmerman AW, Joosten B, Torensma R, Parnes JR, van Leeuwen FN, Figdor CG.

Blood. 2006 Apr 15;107(8):3212-20. Epub 2005 Dec 13.

37.

Cerebrospinal fluid and serum markers of inflammation in autism.

Zimmerman AW, Jyonouchi H, Comi AM, Connors SL, Milstien S, Varsou A, Heyes MP.

Pediatr Neurol. 2005 Sep;33(3):195-201.

PMID:
16139734
38.

Neuroglial activation and neuroinflammation in the brain of patients with autism.

Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA.

Ann Neurol. 2005 Jan;57(1):67-81. Erratum in: Ann Neurol. 2005 Feb;57(2):304.

PMID:
15546155
39.

Cytoskeletal restraints regulate homotypic ALCAM-mediated adhesion through PKCalpha independently of Rho-like GTPases.

Zimmerman AW, Nelissen JM, van Emst-de Vries SE, Willems PH, de Lange F, Collard JG, van Leeuwen FN, Figdor CG.

J Cell Sci. 2004 Jun 1;117(Pt 13):2841-52.

40.

Autism clinical trials: biological and medical issues in patient selection and treatment response.

Anderson GM, Zimmerman AW, Akshoomoff N, Chugani DC.

CNS Spectr. 2004 Jan;9(1):57-64. Review.

PMID:
14999176
41.

Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease.

Pizzini F, Fatemi AS, Barker PB, Nagae-Poetscher LM, Horská A, Zimmerman AW, Moser HW, Bibat G, Naidu S.

AJNR Am J Neuroradiol. 2003 Sep;24(8):1683-9.

42.

Solution structure of fatty acid-binding protein from human brain.

Rademacher M, Zimmerman AW, Rüterjans H, Veerkamp JH, Lücke C.

Mol Cell Biochem. 2002 Oct;239(1-2):61-8.

PMID:
12479569
43.

New insights into the structure and function of fatty acid-binding proteins.

Zimmerman AW, Veerkamp JH.

Cell Mol Life Sci. 2002 Jul;59(7):1096-116. Review.

PMID:
12222958
44.

Postmortem brain abnormalities of the glutamate neurotransmitter system in autism.

Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J.

Neurology. 2001 Nov 13;57(9):1618-28.

PMID:
11706102
45.
46.

Fatty acid-binding proteins of nervous tissue.

Veerkamp JH, Zimmerman AW.

J Mol Neurosci. 2001 Apr-Jun;16(2-3):133-42; discussion 151-7. Review.

PMID:
11478368
47.

Ligand specificity and conformational stability of human fatty acid-binding proteins.

Zimmerman AW, van Moerkerk HT, Veerkamp JH.

Int J Biochem Cell Biol. 2001 Sep;33(9):865-76.

PMID:
11461829
48.

Assessment of neural cell adhesion molecule (NCAM) in autistic serum and postmortem brain.

Purcell AE, Rocco MM, Lenhart JA, Hyder K, Zimmerman AW, Pevsner J.

J Autism Dev Disord. 2001 Apr;31(2):183-94.

PMID:
11450817
49.

Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.

Belsito KM, Law PA, Kirk KS, Landa RJ, Zimmerman AW.

J Autism Dev Disord. 2001 Apr;31(2):175-81.

PMID:
11450816
50.

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

King BH, Wright DM, Handen BL, Sikich L, Zimmerman AW, McMahon W, Cantwell E, Davanzo PA, Dourish CT, Dykens EM, Hooper SR, Jaselskis CA, Leventhal BL, Levitt J, Lord C, Lubetsky MJ, Myers SM, Ozonoff S, Shah BG, Snape M, Shernoff EW, Williamson K, Cook EH Jr.

J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):658-65.

PMID:
11392343

Supplemental Content

Loading ...
Support Center